Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA-Reference-Cited by-同舟云学术

Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA

Published:2017-12 Issue:6 Volume:47 Page:1083-1099.e6
ISSN:1074-7613
Container-title:Immunity
language:en
Short-container-title:Immunity

Author:

Coelho Matthew A.,de Carné Trécesson Sophie,Rana Sareena,Zecchin Davide,Moore Christopher,Molina-Arcas Miriam,East Philip,Spencer-Dene Bradley,Nye Emma,Barnouin Karin,Snijders Ambrosius P.,Lai Wi S.,Blackshear Perry J.,Downward Julian

Funder

Francis Crick Institute

Cancer Research UK

UK Medical Research Council

Wellcome Trust

European Research Council

Wellcome Trust Senior Investigator Award

Intramural Research Program of the National Institute of Environmental Health Sciences, NIH

European Commission Marie Skłodowska-Curie Actions programme, iGEMMdev

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference58 articles.

1. Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors;Akbay;Cancer Discov.,2013

2. In acute myeloid leukemia, B7-H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors;Berthon;Cancer Immunol. Immunother.,2010

3. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer;Borghaei;N. Engl. J. Med.,2015

4. Constitutive ERK activity induces downregulation of tristetraprolin, a major protein controlling interleukin8/CXCL8 mRNA stability in melanoma cells;Bourcier;Am. J. Physiol. Cell Physiol.,2011

5. Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer;Brahmer;N. Engl. J. Med.,2015

Cited by 468 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapeutic strategies in hepatopancreatobiliary cancers;Principles of Immunotherapy Breast and Gastrointestinal Cancers;2025

2. Barriers and opportunities in pancreatic cancer immunotherapy;npj Precision Oncology;2024-09-12

3. Parthenolide Inhibits Synthesis and Promotes Degradation of Programmed Cell Death Ligand 1 and Enhances T Cell Tumor-Killing Activity;Journal of Agricultural and Food Chemistry;2024-09-12

4. CDYL loss promotes cervical cancer aggression by increasing PD-L1 expression via the suppression of IRF2BP2 transcription;Translational Oncology;2024-09

5. CRISPR/Cas-Mediated Knockdown of PD-L1 and KRAS in Lung Cancer Cells;International Journal of Molecular Sciences;2024-08-22